Lonicerae Flos Inhibited COX-2 and MMP-9 in LPS Induced Arthritis of Mouse through Regulation of MIF

LPS 유도 생쥐 관절염에서 금은화의 MIF 활성 조절이 COX-2와 MMP-9 생성 억제에 미치는 영향

  • Ahn, Sang-Hyun (Department of Anatomy, Oriental Medicine College, Dongguk University) ;
  • Kim, Ho-Hyun (Department of Physiology, Oriental Medicine College, Semyung University)
  • 안상현 (동국대학교 한의과대학 해부학교실) ;
  • 김호현 (세명대학교 한의과대학 생리학교실)
  • Received : 2010.01.11
  • Accepted : 2010.03.17
  • Published : 2010.04.25

Abstract

The present study was designed in order to determine whether Lonicerae flos (LF) could mitigate rheumatoid arthritis through inhibition of cyclooxygenase (COX)-2 and matrix metalloproteinase (MMP)-9 by regulation of macrophage migration inhibitory factor (MIF). We found that MIF mRNA expression in synoviocytes stimulated with phorbol-12-myristate-13-acetate dose-dependantly decreased by LF extract treatment (0.4 - 1.0 mg/$m{\ell}$). The distribution of MIF, COX-2 and MMP-9 positive reacted cells in LPS induced arthritis of mice were decreased by LF (45 mg/kg/day) treatment for 28 days. These data likely indicate that LF may act as MIF inhibitor and may be possible to develop useful agent for rheumatoid arthritis.

Keywords

References

  1. Peter, S., Stefan, S., Rolf, M., Peter, P. Synthesis and Degradation of Hyaluronate by Synovia from patients with rheumatoid arthritis. J. Rheumatol. 22: 400-405, 1995.
  2. Leo, A.B., Monique, M.A., Fons, A.J., van de Loo, Wim, B. Anti-cytokine treatment of established type II collagen-induced arthritis in DBA/a mice. Arthritis Rheum. 39(5):797-809, 1996. https://doi.org/10.1002/art.1780390513
  3. Morand, E.F. New therapeutic target in inflammatory disease : macrophage migration inhibitory factor. J. Internal medicine. 35: 419-426, 2005. https://doi.org/10.1111/j.1445-5994.2005.00853.x
  4. Leech, M., Metz, C.N., Smith, M., Weedon, H., Holdsworth, S.R., Bucala, R. MIF in Rheumatoid arthritis : evidence for proinflammatory function and regulation by glucocorticoids. Arthritis Rheum. 42: 1601-1608, 1999. https://doi.org/10.1002/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B
  5. Marc, F., Fionula, M.B., Ravinder, N.M. Role of cytokines in rheumatoid arthritis, Annu. Rev. Immunol. 14: 397-440, 1996. https://doi.org/10.1146/annurev.immunol.14.1.397
  6. Sampey, A.V., Hall, P.H., Mitchell, R.A., Metz, C.N., Morand, E.F. Regulation of synoviocytes phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Arthritis Rheum. 44: 1273-1280, 2001. https://doi.org/10.1002/1529-0131(200106)44:6<1273::AID-ART219>3.0.CO;2-8
  7. Yasmina, J., Catalina, A., Carmen, M., Alicia, A., Irene, G., Florencia, R., Rosa, P., Javier, L. Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis. Arthritis Res. & Therapy. 7: R1034-1045, 2005. https://doi.org/10.1186/ar1779
  8. Burrage, P.S., Mix, K.S., Brinckerhoff, C.E. Matrix metalloproteinases ; role in arthritis. Front Biosci. 11: 529-543, 2006. https://doi.org/10.2741/1817
  9. Onodera, S., Kaneda, K., Mizue, Y., Koyama, Y., Fujinaga, M., Nishihira, J. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblast of rheumatoid arthritis. J. Biol chem. 275: 444-450, 2000. https://doi.org/10.1074/jbc.275.1.444
  10. Matthew, H. Ornstein, Kirk, S. The antiinflammatory and antiviral effects of hydroxychloroquine in two patients with acquired immunodeficiency syndrome and active inflammatory arthritis. Arthritis Rheum. 39(1):157-161, 1996. https://doi.org/10.1002/art.1780390122
  11. 송정수. 류마티스관절염의 완치를 향하여. 대한내과학회지 69(6):581-589, 2005.
  12. 이학인, 양재하, 권순주. 류마토이드 관절염의 동서의학적 고찰, 경산대 濟韓東醫學術院論文集, 4(1):199-209, 1999.
  13. 許人仁, 張再良. 歷節風證治探要. 上海中醫學大學學報, 14(4): 37-39, 2000.
  14. 張浩, 呂愛平. 試論腎虛痺證(類風濕性關節炎) 發育生物學基 礎. 中國中醫基礎醫學雜誌, 9(2):8-10, 2003.
  15. 王炎焱, 黃烽, 路輝. 論中國藥治療風濕性關節炎的硏究思路 中華醫學從刊, 3(12):6-8, 2003.
  16. 전국한의과대학 공동교재편찬위원회. 본초학. 서울, 永林社, pp 198-199, 2004.
  17. 강옥희. 金銀花의 藥理作用에 關한 硏究. 우석대학교 석사학 위논문, 1987.
  18. 배지현, 김미순, 강은혜. 식중독 유발세균의 증식에 미치는 금은화 추출물의 항균효과. 한국식품과학회지 37(4):642-647, 2005.
  19. 문태철, 박정옥, 정광원, 손건호, 김현표, 강삼식, 장현욱, 정규찬. 금은화 플라보노이드 성분의 항염증작용. 약학회지 43(1):117-123, 1999.
  20. Lee, J.H., Ko, W.S., Kim, Y.H., Kang, H.S., Kim, H.D., Choi, B.T. Anti-inflammatory effect of the aqueous extract from Lonicera japonica flower is related to inhibition of NF-kappaB activation through reducing I-kappaBalpha degradation in rat liver. Int J. Mol Med. 7(1):79-83, 2001.
  21. Lee, S.J., Son, K.H., Chang, H.W., Kang, S.S., Kim, H.P. Anti-inflammatory activity of Lonicera japonica. Phytotherapy Research. 12(6):445-447, 1998. https://doi.org/10.1002/(SICI)1099-1573(199809)12:6<445::AID-PTR317>3.0.CO;2-5
  22. Kwak, W.J., Han, C.K., Chang, H.W., Kim, H.P., Kang, S.S., Son, K.H. Loniceroside C, an Antiinflammatory Saponin from Lonicera japonica. Chem Pharm Bull. 51(3):333-335, 2003. https://doi.org/10.1248/cpb.51.333
  23. 황윤정. 주엽나무잎 및 금은화의 phenol성 성분. 충북대학교대학원, 1994.
  24. Rim, B.M., Rim, C.W., Choi, J.Y., Chung, Y.S., Jeong, H.G. Effects of Lonicera japonica extract as a biological response modifier. Environ. Mut. Car. 12(1):45-54, 1992.
  25. 김경진, 한두석. 금은화의 가용성 Ethyl acetate 소분획의 인체 구강유상피암종세포에 대한 항암효과. 원광치의학 8(2):31-41, 1998.
  26. 한두석, 배경현, 김영옥, 최규은, 곽정숙, 백승화. 한국산 생약으로부터 항암물질의 개발(제6보) 금은화 Ethyl Acetate 가용성 분획의 인체 구강유상피암종세포에 미치는 세포독성작용. 생약학회지 29(1):22-27, 1998.
  27. 이금택, 최병태, 이용태, 고우신. 慈雲膏加金銀花가 흰쥐의 創傷에 미치는 效果. 대한한의학회지 20(1):132-141, 1999.
  28. Huang, K.G. The Pharmacology of Chinese herbs. 2nd ed., Boca Ranton: CRC. pp 388-389, 1998.
  29. 이재동. 류마티스 관절염의 한방치료. 경희의학, 20(1):4-9, 2004.
  30. Stephen, L.D., Koda-Kimble, M.A. Rheumatic disorders, Applied Therapeutics: the clinical use of drugs. 6th ed. Applied Therapeutics, Inc. Vancouver, WA : Appl. Therap. Inc. pp 1-27, 1995.
  31. Lipsky, P.E. Rheumatoid arthritis. Harrison's principle of internal medicine, 16th ed. New York, McGraw Hill, pp 1968-1977, 2005.
  32. 許浚. 東醫寶鑑. 서울, 南山堂, p 378, 1983.
  33. 趙浩. 聖濟總論. 北京, 人民衛生出版社, pp 1111-1117, 3129-3174, 1987.
  34. 楊維僯. 黃帝內經素問靈樞譯解. 서울, 成輔社, pp 315-328, 1980.
  35. Tang, W., Eisenbrand, G. Chinese drugs of plant origin. Springer-verlag. Berlin. pp 621-625, 1992.
  36. 陳再民. 原說韓方醫藥大辭典(中國藥學大典). 中國, 講談社, p 160, 1982.
  37. Chung, K.C., Kwon, D.Y., Baek, S.H., Kim, S.H., Chang, H.W. Effect of Lonicera Flos's ethyl acetate fraction on mutagenicity. Yakhak Hoeji. 32: 328-333, 1988.
  38. Choi, C.W., Jung, H.A., Kang, S.S., Choi, J.S. Antioxidant constituents and a new triterpenoid glycoside from Flos Lonicerae. Arch Pharm Res. 30(1):1-7, 2007. https://doi.org/10.1007/BF02977770
  39. Chang, C.W., Lin, M.T., Lee, S.S., Liu, K.C., Hsu, F.L., Lin, J.Y. Differential inhibition of reverse transcriptase and cellular DNA polymerase-alpha activities by lignans isolated from Chinese herbs, Phyllanthus myrtifolius Moon, and tannins from Lonicera japonica Thunb and Castanopsis hystrix. Antiviral Res. 27(4):367-374, 1995. https://doi.org/10.1016/0166-3542(95)00020-M
  40. Chang, H.W., Baek, S.H., Chung, K.W., Son, K.H., Kim, H.P., Kang, S.S. Inactivation of phospholipase A2 by naturally occurring biflavonoid, ochnaflavone. Biochem Biophys Res Commun. 205(1):843-849, 1994. https://doi.org/10.1006/bbrc.1994.2741
  41. Lee, J.H., Ko, W.S., Kim, Y.H., Kang, H.S., Kim, H.D., Choi, B.T. Anti-inflammatory effect of the aqueous extract from Lonicera japonica flower is related to inhibition of NF-kappaB activation through reducing I-kappaBalpha degradation in rat liver. Int J Mol Med. 7(1):79-83, 2001.
  42. Suh, S.J., Chung, T.W., Son, M.J., Kim, S.H., Moon, T.C., Son, K.H., Kim, H.P., Chang, H.W., Kim, C.H. The naturally occurring biflavonoid, ochnaflavone, inhibits LPS-induced iNOS expression, which is mediated by ERK1/2 via NF-kappaB regulation, in RAW264.7 cells. Arch Biochem Biophys. 447(2):136-146, 2006. https://doi.org/10.1016/j.abb.2006.01.016
  43. Carlene, T., Luis, A.D., Nora, G.S., Lan, L.L., Anita, H.K., Raj, M., Brian, J.N., Leslie, J.C., David, A.F. Responsiveness of Human T Lymphocytes to Bacterial superantigens presented by cultured Rheumatoid Arthritis Synoviocytes, Am. College Rheumto. 39(1):125-136, 1996.
  44. Mizel, S.B., Dayer, J.M., Krane, S.M., Mergenhagen, S.E. Stimulation of Rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte activating factor(IL-1). Proc. Natl. Acad. Sci. USA. 78: 2474-2486, 1981. https://doi.org/10.1073/pnas.78.4.2474
  45. Pettipher, E.R., Higgs, G.A., Henderson, B. IL-1 induces leukocytes infiltration and cartilage proteoglycan degradation in the synovial joint. Proc. Natl. Acad. Sci. USA 83: 8749-8756, 1986. https://doi.org/10.1073/pnas.83.22.8749
  46. Saklatvala, J. IL-1 - Purification and biochemical aspects of its action on cartilage. J. Rheum. 14: 52-58, 1987.
  47. Bunning, R., Crawford, A., Richardson, H., Opendakker, G., van Damme, J., Russell, R. IL-1 preferentially stimulates the production of tissue-type plasminogen activator by human articular chondrocytes. Biochem. Biophys. Acta. 924: 437-449, 1987.
  48. Baeuerle, P.A. I$\kappa$B-NF$\kappa$B structure: at the interface of inflammation control. Cell. 95: 729-731, 1998. https://doi.org/10.1016/S0092-8674(00)81694-3
  49. Y.X. Li, N. Li, Y.S. Li, B. Wu, J.S. Li. Upregulated intragraft gene expression, ICAM-1 and IL-2R molecules, and apoptotic epithelial cells during rejection of rat small intestine allgrafts. Transplant Proceed. 32: 1283-1286, 2000. https://doi.org/10.1016/S0041-1345(00)01227-6
  50. Groszmann, R.J. Hyperdynamic state in chronic liver diseases. J Hepatol. 17(2):S38-40, 1993. https://doi.org/10.1016/S0168-8278(05)80454-4
  51. RothkOtter, H.J., Pabst, R., Bailey, M. Lymphocyte migration in the intestinal mucosa : entry, transit and emigration of lymphoid cells and the influence of antigen. Vetrinary Immuno immunopath. 72: 157-165, 1999. https://doi.org/10.1016/S0165-2427(99)00128-2
  52. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., DuBois, R.N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 93(5):705-716, 1998. https://doi.org/10.1016/S0092-8674(00)81433-6